Figure 4.
Representative immunoblots. Leukemic cell lysates of 2 B-CLL patients (lanes 1-2) and PBMCs of a normal healthy control donor (lane 3) incubated with anti-fibromodulin antibody (top) and anti-major histocompatibility complex (MHC) class 1 antibody (bottom) (see “Patients, materials, and methods”).